미숙아 동맥관개존증의 지연된 폐쇄가 예후에 미치는 영향 = Delayed closure effect in preterm infants with patent ductus arteriosus

다국어 초록 (Multilingual Abstract)

Purpose: This study aims to determine whether early closure (within 7 d) of significant patent ductus arteriosus (PDA) with indomethacin or ligation reduces neonatal morbidity when compared with delayed closure (after 7 d).
Methods:Fifty-eight extremely-low-birth-weight infants admitted to the NICU of Seoul National University Hospital from April 2005 to May 2007 with PDA were studied retrospectively.
Results:The mean gestational age (GA) was 26±2 weeks (range, 23-32 wk), and the birth weight was 782±146 g (range, 430-990 g). The delayed closure group was associated with early GA (25.7±1.7 wk vs. 27.1±2.0 wk, P=0.013), in vitro fertilization (IVF) (55% vs 24%, P=0.017), and the absence of preeclampsia (5% vs. 34%, P=0.013). There was no difference in ductal size between the early closure and delayed closure groups. The incidence of bronchopulmonary dysplasia (95% vs 65%, P=0.012) and intraventricular hemorrhage (70% vs. 39%, P=0.027) increased in the delayed closure group. Using regression analysis adjusted for gestational age, delayed closure correlated positively with the duration of ventilator support (P=0.008), hospitalization (P=0.020), time to full enteral feeding (P<0.001), and total parenteral nutrition (P=0.010)..
Conclusion:Delayed closure of the hemodynamically significant patent ductus arteriosus in extremely-low-birth-weight infants is significantly related to the development of various morbidities. Thus, early closure of PDA is needed within the first week of life. (Korean J Pediatr 2008;51:1065-1070)

국문 초록 (Abstract)

목 적 : 초극소 체중아에서 혈역학적으로 의미 있는 동맥관 개존증은 심각한 합병증의 발생을 증가시키나 동맥관 폐쇄에 대한 적절한 시점과 치료 방법에 대한 원칙은 없는 실정이다. 본 연구는 혈역학적으로 의미 있는 동맥관 개존증의 지연된 폐쇄가 예후에 미치는 영향을 분석하고자 하였다.
방 법 : 2005년 3월부터 2007년 5월까지 본원 신생아중환자실에 입원한 1,000 g 미만의 동맥관개존증 환아 58례(26±2 wk, 782±146 g)를 대상으로 조기 폐쇄군(생후 7일 이내 폐쇄) 38례와, 지연 폐쇄군(생후 7일 이후 폐쇄) 20례로 분류하여 분석하였다. 혈역학적으로 의미 없는 동맥관 개존증 4례, 선천성 기형 1례, 생후 7일 이내에 사망한 3례는 제외되었다.
결 과 : 대상 환아 58명의 평균 재태 주령은 26±2주, 출생체중은 782±146 g이었다. 주산기 요인으로 지연 폐쇄군에서 재태주령이 짧고(25.7±1.7 wk vs 27.1±2.0 wk), 체외 수정의 빈도가 높았으며(55% vs 24%, P=0.017), 산모의 전자간증이 적었다(5% vs 34%, P=0.013). 동맥관 직경은 조기 폐쇄군과 지연 폐쇄군 간에 통계학적으로 유의한 차이가 없었다. 기관지 폐 이형성증(95% vs 65%, P=0.012), 뇌실내 출혈(70% vs 39%, P=0.027), 비정상적 청력검사 결과(32% vs 8%, P=0.024)는 지연 폐쇄군에서 유의하게 증가하였다. 또한 재태주 령을 보정한 다중회귀분석에서 동맥관 폐쇄가 지연될수록 인공 환기 치료기간(r2=0.362, P= 0.008), 총 입원기간(r2=0.257, P=0.020), 완전 장관수유까지 걸린시간(r2=0.305, P<0.001), 총 정맥영양기간(r2=0.224, P=0.010)이 유의하게 증가하였다.
결 론 : 초극소 체중아에서 혈역학적으로 의미 있는 동맥관 개존증은 폐쇄가 지연될수록 여러 합병증을 유발하므로 출생 1주 이내에 적극적인 약물적, 수술적 치료가 필요할 것으로 생각된다.

참고문헌 (Reference)

• 1 Knight DB, "The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials" 6 : 63-73, 2001
• 2 Koch J, "Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1,000 grams or less" 117 : 1113-1121, 2006
• 3 Clyman RI, "Regulation of ductus arteriosus patency by nitric oxide in fetal lambs: the role of gestation, oxygen tension, and vasa vasorum" 43 : 633-644, 1998
• 4 Clyman RI, "Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies" 128 : 601-607, 1996
• 5 Narayanan M, "Prophylactic indomethacin: factors determining permanent ductus arteriosus closure" 136 : 330-337, 2000
• 6 Clyman RI, "Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia, and gestation" 45 : 19-29, 1999
• 7 Clyman RI, "Payne B. Effect of gestational age on ductus arteriosus response to circulating prostaglandin E2" 102 : 907-911, 1983
• 8 Clyman RI, "Patent ductus arteriosus: evidence for and against treatment" 150 : 216-219, 2007
• 9 Raval MV, "Patent ductus arteriosus ligation in premature infants: who really benefits, and at what cost?" 42 : 69-75, 2007
• 10 Koehne PS, "Patent ductus arteriosus in very low birth weight infants: complications of pharmacological and surgical treatment" 29 : 327-334, 2001
• 11 Bancalari E, "Patent ductus arteriosus and respiratory outcome in premature infants" 88 : 192-201, 2005
• 12 Chorne N, "Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity" 119 : 1165-1174, 2007
• 13 Lee LC, "Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis" 6 : 15-20, 2006
• 14 Trus T, "Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g" 28 : 1137-1139, 1993
• 15 Palder SB, "Management of patent ductus arteriosus" 22 : 1171-1174, 1987
• 16 Schmidt B, "Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants" 344 : 1966-1972, 2001
• 17 Tuder RM, "Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia" 95 : 1798-1807, 1995
• 18 Matejevic D, "Hyaluronan and CD44 in maternal serum in pre-eclampsia" 203 : 246-249, 1999
• 19 Kluckow M, "Functional echocardiography: an emerging clinical tool for the neonatologist" 150 : 125-130, 2007
• 20 Weiss H, "Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin" 127 : 466-471, 1995
• 21 Gersony WM, "Effects of indomethacin in premature infants with patent ductus arteriosus: results of national collaborative study" 102 : 895-906, 1983
• 22 Colditz P, "Effect of infusion rate of indomethacin on cerebraovascular responses in preterm neonates" 64 : 8-12, 1989
• 23 Van Overmeire B, "Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome" 138 : 205-211, 2001
• 24 Lee HC, "Diagnosis of patent ductus arteriosus by a neonatologist with a compact, portable ultrasound machine" 27 : 291-296, 2007
• 25 Yeh TH, "Clinical evaluation of premature infants with patent ductus arteriosus: A scoring system with echocardiogram, acid- base, and blood gas correlations" 99 : 655-657, 1981
• 26 Cassady G, "A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1,000 g or less at birth" 320 : 1511-1516, 1989
• 27 Van Overmeire B, "A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus" 343 : 674-681, 2000